4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Tiziana Life Sciences Ltd (TLSA) operates in the Biotechnology industry and is headquartered in London, United Kingdom with about 10 employees. Its market capitalization is roughly $160 million. In the fiscal year ended 2025-12-31, TLSA reported $0M in revenue and ($18M) in net income.
Tiziana Life Sciences Ltd, together with its subsidiaries, engages in the research and development of therapies for neurodegenerative and neuroinflammatory diseases in the United Kingdom and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | — |
| Gross Profit | — | — | — | — | $0M |
| Operating Income (EBIT) | ($21M) | ($16M) | ($18M) | ($15M) | — |
| Net Income | ($18M) | ($12M) | ($18M) | ($15M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $12M | $11M | $12M | $26M | — |
| Total Liabilities | $11M | $7M | $7M | $7M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive TLSA viewer.
About TickerBase · Data methodology & sources